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Our charge was to assess whether monitoring
of diabetes rates could be used as a method
for detecting community exposure to critical
pollutants. This question arose from the
observation that the frequency of hospital
admissions for diabetes varied substantially
among several areas (Areas of Concern) on
the border of the United States and Canada
(1). The possibility that a corresponding dis-
tribution of toxic substances might account
for the variation was suggested by scientists at
the International Joint Commission, who
advise the two governments on the Great
Lakes Water Quality Agreement (2). We
responded to their charge by reviewing data
on whether environmental factors might be
responsible for variation in rates of diabetes.
The notion that environmental contami-
nants could increase risk of diabetes is fairly
new (3–5). That occupational exposure
could increase risk, however, has been recog-
nized since the 1970s, when an association
with carbon disulﬁde was reported (6). Here
we review the relevant epidemiologic data,
which can be categorized as follows: type 1
diabetes in relation to nitrates, nitrites, and
nitrosamines, and in relation to polychlori-
nated biphenyls (PCBs); and type 2 diabetes
in relation to arsenic, 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD), and occupa-
tional exposures. We included occupational
exposures in our review because they could
affect local disease rates if the area around
the industry were polluted or if a large
proportion of the work force in a given area
were employed by one industry. We begin
with a brief description of the main types of
diabetes and their epidemiology.
Type 1 diabetes results from decreased
insulin production by the pancreatic β cells.
β-cell deficiency is due to autoimmune
processes, or, in some cases, to idiopathic
destruction (7). The autoimmune process
against β cells is thought to be triggered by a
combination of genetic predisposition and
environmental factors. The concordance of
type 1 diabetes among monozygotic twins is
20–35% (8,9), suggesting that environmental
factors play a large role in the etiology. The
environmental factors usually considered etio-
logically relevant are infectious agents or
dietary factors that stimulate an immune
response (10). Poisonings with the rodenticide
Vacor (Rohm and Haas Co., Philadelphia,
PA), however, have caused type 1 diabetes
(11). Furthermore, certain drugs, such as pen-
tamidine, can be toxic to β cells (12). Agents
that cause type 1 diabetes in animal models
act through a variety of mechanisms (13),
though all rely on toxins fairly specific for
pancreatic β cells, such as alloxan and strepto-
zotocin. Vacor, alloxan, and streptozotocin all
include a urea structure; streptozotocin is also
an N-nitroso compound.
The onset of type 1 diabetes is typically
before adulthood. The incidence in whites is
greater than in blacks or Asians (14). The inci-
dence of type 1 diabetes has been increasing
worldwide for approximately 40 years, with an
average yearly increase in incidence of 3%
(15). A typical incidence rate is 10/105
person-years (world population standard),
though rates vary markedly and are much
higher in selected developed countries.
Clustering of cases of type 1 diabetes, diag-
nosed among children who were together
during a deﬁned period, further supports an
environmental component to the etiology
(16–18). These cluster studies, however,
offer little that allows one to distinguish the
effect of contaminants from those of infec-
tious agents or exposures that stimulate an
immune response.
Type 2 diabetes is due to resistance to
insulin action and a relative deficiency of
insulin. Age, obesity, central adiposity, lack of
physical activity, and dietary glycemic load are
the main factors identiﬁed as responsible for
the disease (19). The concordance rate among
monozygous twins is about 30% (9). Whether
chemical agents can cause type 2 diabetes in
humans is not as clearly established as for
type 1 diabetes, though suggestive data exist
(6). Many drugs, however, exacerbate type 2
diabetes (20). As with type 1 diabetes, animal
models of type 2 diabetes rely on a variety of
mechanisms, and many include an element of
impaired insulin action (21).
The onset of type 2 diabetes is typically
during adulthood. Disease is more frequent
among blacks, Mexican–Americans, and
Native Americans (14). The prevalence of
diabetes of all types was 6.5% in the United
States in 1998 (22), with approximately
90–95% of cases due to type 2 diabetes (23).
The prevalence of type 2 diabetes in the
United States has increased by 33% during
the past decade (22,23). This increase has
been attributed to the rise in the prevalence of
obesity (22). Worldwide the prevalence of
type 2 diabetes varies roughly 10-fold, and
the number of people with diabetes has
increased 11% in the past 5 years (24).
For both type 1 and type 2 diabetes mellitus, the rates have been increasing in the United States
and elsewhere; rates vary widely by country, and genetic factors account for less than half of
new cases. These observations suggest environmental factors cause both type 1 and type 2
diabetes. Occupational exposures have been associated with increased risk of diabetes. In
addition, recent data suggest that toxic substances in the environment, other than infectious
agents or exposures that stimulate an immune response, are associated with the occurrence of
these diseases. We reviewed the epidemiologic data that addressed whether environmental
contaminants might cause type 1 or type 2 diabetes. For type 1 diabetes, higher intake of
nitrates, nitrites, and N-nitroso compounds, as well as higher serum levels of polychlorinated
biphenyls have been associated with increased risk. Overall, however, the data were limited or
inconsistent. With respect to type 2 diabetes, data on arsenic and 2,3,7,8-tetrachlorodibenzo-p-
dioxin relative to risk were suggestive of a direct association but were inconclusive. The
occupational data suggested that more data on exposure to N-nitroso compounds, arsenic,
dioxins, talc, and straight oil machining ﬂuids in relation to diabetes would be useful. Although
environmental factors other than contaminants may account for the majority of type 1 and type 2
diabetes, the etiologic role of several contaminants and occupational exposures deserves further
study. Key words: arsenic, diabetes mellitus, epidemiology, nitrates, nitrites, nitroso
compounds, occupations, polychlorinated biphenyls, tetrachlorodibenzodioxin. — Environ Health
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Regardless of type, patients with diabetes
mellitus are at increased risk of small and
large blood vessel disease and hyperlipidemia,
resulting in retinopathy, neuropathy, vascular
diseases such as myocardial infarction, stroke,
aneurysm, and kidney failure, and they are
also at increased risk of depression (25). The
cost of diabetes in the United States in 1992
was estimated at $90 billion (26).
For both type 1 and type 2 diabetes,
genetic factors by themselves appear to
account for less than half of the disease; inci-
dence rates have increased over relatively
short periods, and incidence rates vary
widely across geographic areas. These obser-
vations suggest that environmental factors,
broadly defined, account for much of the
disease (27). Temporal and spatial variations
in disease frequency, however, are non-
specific with respect to the etiologic agents
involved (28). Because environmental conta-
minants that are diabetogenic in humans are
plausible, we will consider the evidence that
any might be associated with risk of dia-
betes. In our discussion we briefly address
whether the variation in rates of diabetes in
the Areas of Concern might be related to the
contaminants identiﬁed in this review.
Potential Risk Factors for 
Type 1 Diabetes 
Nitrates, Nitrites, and Nitrosoamines
In the gastrointestinal tract, nitrates can be
converted to nitrites, and nitrites can react
with amines to form N-nitroso compounds.
Because of this interrelatedness, we have
considered the data for these nitrogen-
containing compounds together. Drinking
water can be contaminated with nitrates result-
ing from fertilizer application. Foods contain
nitrates, nitrites, and N-nitroso compounds. 
In 1981 Helgason and Jonasson (29) ﬁrst
drew attention to the possibility that
N-nitroso compounds may cause type 1 dia-
betes in humans. Consumption early in preg-
nancy of cured mutton, a source of N-nitroso
compounds, was followed by a high incidence
of type 1 diabetes in male offspring. They
proposed that dietary nitrosamine activity was
inhibited by estrogen and promoted by
testosterone, as with streptozotocin, thus
accounting for the male speciﬁcity. Helgason
et al. (30) subsequently induced diabetes in
the progeny of mice fed N-nitroso–laden
mutton, and males were preferentially
affected. Subsequent in vitro work revealed
that selected N-nitroso compounds were
especially toxic to pancreatic β cells (31).
Associations between regional water nitrate
levels and the incidence of type 1 diabetes have
been reported in three ecologic studies (Table
1). Kostraba et al. (3) found a positive correla-
tion even though the range of average nitrate
levels was relatively limited. The association,
however, appeared to be inﬂuenced greatly by
data from one or two counties. Parslow et al.
(32) reported that the rate of diabetes was 30%
higher among those in water supply zones with
average nitrate levels of 14.9–40 mg/L com-
pared with those in areas with means less than
3.2 mg/L. Van Maanen et al. (33) reported a
50% increase in rates when nitrate levels
exceeded 25 mg/L, compared with levels less
than 10 mg/L, though the conﬁdence interval
(CI) for this increase was wide and included
one. The average nitrate concentrations in all
areas of all three studies were below the current
World Health Organization standard (50
mg/L) (34). Although the data from these
studies are consistent with the nitrate hypothe-
sis, they provide only modest support because
of the possibility that correlates of water nitrate
level could account for the associations
observed. This possibility is better addressed by
data from case–control studies. In addition,
drinking water exposure data could possibly be
improved if seasonal variation in nitrate levels
were assessed. 
Data from case–control studies on
childrens’ dietary intakes of nitrogen-
containing compounds and type 1 diabetes
(35–37) show a mixture of results (Table 2).
Virtanen et al. (36) estimated intake of
nitrate and nitrite from drinking water and
found no relation with risk (not shown in
table). The intake of nitrates and nitrites
from food was much greater than from water
(36). Because the absolute intake of N-
nitroso compounds, nitrates, and nitrites was
not reported in most studies (35,37), it is
possible that low exposure levels in some
studies was responsible for lack of association
(37). A further uncertainty is whether nitrate
is equally toxic in food and in water. 
In summary, some data suggest an associ-
ation between intake of nitrogen-containing
compounds and risk of type 1 diabetes.
Overall, however, the data are limited and
inconsistent.
Polychlorinated Biphenyls
In a recent small study of pregnant women,
serum levels of PCBs were 30% higher
among those with diabetes (primarily type 1)
than among those without (38). Because the
study was cross-sectional, whether the associa-
tion was causal could not be determined. If
the association is conﬁrmed by others, studies
designed to assess whether the association is
causal would be in order.
Table 1. Summary of results from ecologic studies of average water nitrate levels in relation to incidence of type 1
diabetes.
Number of Exposure
First author, year  Site geographic units levels (mg/L) Results Comments
Kostraba, 1992 (3) Colorado,  63 Counties 0 – 8.2 r = 0.23 p = 0.07; 2 
United States inﬂuential counties
Parslow, 1997 (32) Yorkshire,  148 Water supply  1.5 – <3.2 RR 1 
United Kingdom zones 3.2 – <14.9 RR 1.1 
14.9 – 41.0 RR 1.3*
Van Maanen, 2000 (33) The Netherlands 3,932 Postal code <10 RR 1
areas 10 – 25 RR 1.0
>25 RR 1.5
Abbreviations: r, Pearson correlation coefﬁcient; RR, relative risk. *p < 0.05.
Table 2. Summary of results from case–control studies of dietary nitrates, nitrites, and nitrosamines in relation to
type 1 diabetes.
Number Exposure Odds
First author, year  Site  of cases Exposure quartile  ratio
Dalquist, 1990 (35) Sweden 339 Nitrosamine in food 1 1
2–3 1.7*
4 2.6*
Nitrate and nitrite in food 1 1
2–3 0.8
4 2.4*








Verge, 1994 (37) Australia 217 Nitrosamine in food 1 1
2a 0.7
3 1.1
aVerge et al. (37) used tertiles. *p < 0.05.Environmental contamination and diabetes
Potential Risk Factors 
for Type 2 Diabetes 
Arsenic
Epidemiologic data for populations with high
exposure to arsenic, including selected indus-
trial groups, are generally consistent with an
increased risk of type 2 diabetes (Table 3). In
several studies of other populations with high
arsenic exposure, investigators have not
specifically reported results for diabetes
(44–47), raising the possibility that no
notable associations were present.
Compared with the arsenic exposure levels
among the populations represented in Table 3
(4,39,40), exposure levels in the general U.S.
population are much lower, with a mean
drinking water level of about 0.001 mg/L (48).
Within the United States, some areas have
higher levels of exposure, for example, in parts
of Utah where the average water arsenic levels
are roughly 0.1 mg/L (49). A study among the
Utah population that had increased exposure
(49) showed that the overall rate of death from
diabetes was not increased compared with the
rate from the rest of Utah.
Arsenic is metabolized in vivo to trivalent
arsenic. A trivalent arsenical, phenylarsine
oxide, has adverse effects on the insulin
receptor and glucose transport in in vitro
experiments (50). 
The available epidemiologic data on
arsenic and diabetes are suggestive but incon-
clusive because of the limited number of
studies, their small size, and the possibility of
publication bias. The available data do not
address the dose–response issue in detail. If
arsenic exposure via drinking water does
increase risk of type 2 diabetes, this may
occur only among those consuming water
with an arsenic concentration of more than
0.1 mg/L. This is potentially an extremely
serious problem in Bangladesh, where up to
30 million people may be drinking arsenic-
contaminated water (51).
2,3,7,8-Tetrachlorodibenzo-p-dioxin
We identified 11 reports that addressed the
relation of TCDD with type 2 diabetes,
hyperglycemia, or hyperinsulinemia (Table 4).
Most of the studies were of workers exposed
to TCDD (52–55,57,59,60). Cranmer et al.
(61) studied community members living near
a toxic waste disposal site, and Pesatori et al.
(58) reported on the experience of those living
near a TCDD-laden plume resulting from an
out-of-control reaction in a chemical plant.
Vietnam veterans exposed to TCDD in Agent
Orange were the subjects in the report by
Henriksen et al. (56). A group of veterans not
exposed to Agent Orange were the subjects in
the report by Longnecker and Michalek (5).
We excluded from this review two studies that
examined diabetes in veterans who had served
in the Vietnam War but for whom no serum
TCDD levels were available (62,63). Most
Vietnam veterans were not exposed to
TCDD more than other groups with back-
ground-level exposure (64,65); exceptions
were veterans in the Chemical Core and in
Operation Ranch Hand who came in contact
with Agent Orange. 
The results of the 11 studies were catego-
rized according to type of outcome and expo-
sure level (Table 5). Of the studies showing
an unequivocally positive association, none
are very convincing on close examination.
The results from the Seveso study (58)
were unequivocally positive among women
but not among men. The relative risk of 1.9
(95% CI, 1.1–3.2) among the highly exposed
women in Zone B was adjusted for age but
not other risk factors.
The group of highly exposed Czech
workers (mean age 46 years) (52) had a higher
prevalence of diabetes than those 20–79 years
of age in the Czech Republic (24). But in the
absence of a statistical comparison of preva-
lences and the possibility that confounding
factors accounted for the increase, whether the
prevalence of diabetes was notably greater
than expected remains in doubt.
Although the study by Henriksen et al.
(56) was a cohort study, the TCDD serum
levels used to assess exposure were measured
within a few years of when diabetes and
related outcomes were ascertained. Thus, if
diabetics or subjects with subclinical glucose
intolerance had a slower rate of excretion of
TCDD, this could account for the association
observed (66). Furthermore, the prevalence of
diabetes in veterans exposed to Agent Orange
was not greater than in the unexposed com-
parison group. The results from the study by
Longnecker and Michalek (5) suffer from the
same weakness outlined for the study by
Henriksen et al. (56).
The positive finding in the study by
Cranmer et al. (61) was an association of
TCDD level with hyperinsulinemia on a glu-
cose tolerance test (GTT). Although this is
consistent with a TCDD–type 2 diabetes rela-
tion, no association with glucose was found.
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Table 3. Risk of type 2 diabetes in groups highly exposed to arsenic relative to less-exposed groups, by type of
exposure.
Number of Mean exposure 
First author, year  Place or type exposed cases levela,b RRa Study design
Exposure via drinking water
Tseng, 2000 (39) Taiwan 41 0.8 mg/L water 4* Ecologic
Tsai, 1999 (40) Taiwan 188 0.8 mg/L water 1.4* Ecologicc
Rahman, 1998 (4) Bangladesh 21 0.5 mg/L water 6* Cross-sectional
Occupational exposure
Rahman, 1995 (41) Copper smelter 10 0.5 mg/m3 air 4 Nested case–control
Rahman, 1996 (42) Glass workers 31 Unknown 1.4 Nested case–control
Bartoli, 1998 (43) Glass workers 3 Unknown 0.34d Occupational cohort
aApproximate. bAmong the exposed group. cThe subjects in the Tseng et al. study (39) and Tsai et al. study (40) overlapped somewhat
(Putai Township). dValue shown is reported SMR/100.*p < 0.05.
Table 4. Description of studies on TCDD in relation to type 2 diabetes or hyperglycemia.
Number exposed
With
First author, year  Exposure level Total diabetes Association Outcome 
Pazderova-Vejlupkova, 1981 (52) High 55 11 + GTTa
Suskind, 1984 (53) High 200 ∅ Glucose
Ott, 1994 (54) High 134 ± Glucose
Zober, 1994 (55) High 158 10 – Diabetes
Henriksen, 1997 (56) Medium 989 146 + Diabetes, GTT
Calvert, 1999 (57) High 281 26 ± Diabetes, glucose
Pesatori, 1998 (58) High 132 + Mortalityb
Vena, 1998 (59) High 33 ± Mortality
Steenland, 1999 (60) High 89 ∅ Mortality
Longnecker, 2000 (5) Low 1,197 169 + Diabetes, GTT
Cranmer, 2000 (61) Low–moderate 69 + Insulin, GTTc
Abbreviations: –, inverse relation; ∅, no association; ±, equivocally positive association; +, unequivocally positive association. aStudy
design was case series; n = 1 based on one-fifth of cases with abnormal GTT. bResults for females were unequivocally positive.
cIncreased insulin level was the positive ﬁnding.
Table 5. A tally of study results on TCDD in relation to




Medium–high exposed | |  |
Morbidity studies
Low–moderate exposed ||
Medium–high exposed |  | ||  ||
Abbreviations: –, inverse relation; ∅, no association; ±, equivo-
cally positive association; +, unequivocally positive association.
aThe studies from which results were tallied are listed in Table 4. Longnecker and Daniels
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Several of the studies with equivocally
positive results also have notable weaknesses.
The populations studied by Ott et al. (54)
and Zober et al. (55) were basically the same,
but the results of these two studies appear to
be inconsistent with each other (Table 4).
Calvert et al. (57) found that the workers
with the highest serum TCDD levels also had
the highest serum glucose levels compared
with those of an unexposed group, but within
the group of exposed workers there was no
dose–response relation between TCDD levels
and serum glucose or prevalence of diabetes.
Overall, the data on TCDD exposure in
relation to diabetes and hyperglycemia are
mixed. Compelling studies supporting a
causal effect of TCDD on diabetes are absent.
We note, however, that Enan et al. (67) have
shown that TCDD decreases cellular glucose
update, thus a diabetogenic effect of TCDD
is biologically plausible.
Occupational Exposures
In this section we review data on diabetes in
relation to occupational exposures. Data for
workers exposed to arsenic and TCDD, how-
ever, were considered above with the relevant
nonoccupational data. The statistical power
of occupational mortality studies, such as
those shown in Table 6, to detect increases
due to diabetogenic exposures is limited
because a) reporting of diabetes on death cer-
tificates is highly variable and death certifi-
cates reflect less than half of the diabetes
among the deceased (80), b) the assessment of
exposure may lack sufﬁcient detail, and c) the
number of exposed subjects who develop dia-
betes is relatively small in typical occupational
cohort studies. In addition, exposures in the
occupational setting are generally mixed and
not specific with respect to toxic substances
implicated. 
Among rubber workers, a moderately
increased mortality from diabetes was
reported in two cohorts (68,69,81). Two sub-
groups of rubber workers were identified by
McMichael and colleagues (69,81) as having
the greatest risk of diabetes: a) those in
inspection, ﬁnishing, and repair, and b) those
in janitoring, trucking, power plant, and test
driving. In the report by Andjelkovic et al.
(69), the overall standardized mortality ratio
(SMR) for diabetes was only slightly elevated
at 117, but when the deaths occurring only
during retirement were considered, the SMR
was 135 (p < 0.05). Similarly, Weiland and
colleagues (70) found that mortality from dia-
betes was greater among retired rubber work-
ers (SMR = 181; 95% CI, 131–244) than
among active workers (SMR = 152; 95% CI,
112–201). The greater risk of occupation-
associated diabetes seen after retirement
(69,70) ﬁts with the hypothesis that an occu-
pation-induced susceptibility to type 2 dia-
betes could be unmasked by the increased
sedentarism and obesity that accompany
retirement. Exposure to N-nitroso compounds
in the rubber industry has been high (82),
although exposure to other agents such as β-
naphthylamine, benzene, polycyclic aromatic
hydrocarbons, solvents, fumes from vulcaniza-
tion, and talc has also been frequent. 
Data on mortality from diabetes among
pulp and paper mill workers have been pre-
sented in three reports (71–73), with a mod-
erate excess of diabetes evident in two
(71,72). Although exposure to numerous
chemicals and other substances occurs in the
pulp and paper industry, potentially notable
agents are dioxins and talc.
Among a group of chemical industry
workers, deaths from diabetes were double
the expected number (74). Among the many
exposures in that group, none were specifi-
cally linked to diabetes. In a smaller study
among chemical and refinery workers, there
was no overall excess of diabetes (75). Among
the subset who did at least some work in the
chemical plant, however, an SMR of 173 was
found, although this was not statistically sig-
niﬁcant (three observed cases). 
Dry-cleaning workers have been exposed
to several solvents, with tetrachloroethylene
the main agent in use since the 1950s (77). In
the two studies of laundry and dry-cleaning
workers reporting results speciﬁcally for dia-
betes, an excess of death from diabetes was
found in one study (76) but not in a second
smaller one (77).
Excess mortality from diabetes was also
found among workers involved in engine
manufacturing (78). Exposure speciﬁcally to
machining ﬂuid was associated with increased
risk. Some machining fluids contain
N-nitroso compounds, but the straight oils
implicated in this study did not.
In a study of a group of pesticide users
and an unexposed group, Morgan et al. (79)
found that subjects with diabetes, compared
with those without diabetes, had higher
blood levels of 1,1,1-trichloro-2,2-bis(p-
chlorophenyl)ethane (DDT) and its metabo-
lite 1,1-trichloro-2,2-bis(p-chlorophenyl)
ethylene (DDE). As with the studies of
TCDD, the possibility exists that subjects
with diabetes or prediabetes excreted
organochlorines (in this case DDT and
DDE) more slowly.
An excess of diabetes has also been
reported among workers exposed to heat
stress (83) and among those with sedentary
occupations (81,84). Because these associa-
tions were likely due to confounding by body
mass index or low physical activity, we con-
sidered them outside the scope of this review.
Trivalent chromium is an essential nutrient,
and supplementation improves glucose toler-
ance in most clinical trials (85). A study of
tannery workers occupationally exposed to
chromium found a lower prevalence of
impaired glucose tolerance and of diabetes
mellitus than in the control group, even
though the exposed workers were more
obese; the results, however, were statistically
significant only among workers more than
48 years of age (86). In other studies of
chromium-exposed tannery workers, investi-
gators have generally not presented results for
diabetes (87,88), although in one study
exposed workers had an SMR of 130 (95%
CI, 67–227) (89). 
In summary, the occupational data show
for both rubber and pulp and paper mill
workers an excess of diabetes deaths in more
than one study (68,70–72), but results were
mixed (69,73). Complete investigations of
occupational risks would need to account for
the level of physical activity and body mass
index associated with a given exposure.
Discussion
Environmental Contaminants and
Increased Rates of Diabetes
Available data on drinking water nitrates do
not exclude the possibility that nitrates affect
risk of type 1 diabetes, but neither were they
strongly supportive of an association. More
Table 6. Summary of data on diabetes in selected occupational groups.
First author, year Industry/occupation Number of cases SMR
McMichael, 1974 (68) Rubber 43 143*
Andjelkovic, 1976 (69) Rubber 48 117
Weiland, 1996 (70) Rubber 49 152*
Schwartz, 1988 (71) Pulp, paper mill 22 146*,a
Wingren, 1991 (72) Pulp, paper mill 46 130*,b
Wong, 1996 (73) Pulp, paper mill 17 110
Wong, 1984 (74) Chemical 19 220*
Marsh, 1991 (75) Chemical, reﬁnery 9 77
Katz, 1981 (76) Laundry, dry cleaning  25 177*,a
Blair, 1979 (77) Laundry, dry cleaning  9 103a
Park, 1996 (78) Engine manufacturing  25 150*,a
Morgan, 1980 (79) Pesticide users 58 >100*,c
aProportional mortality ratio. bOriginally presented as an odds ratio; here shown ×100. cDDE/DDT levels in cases signiﬁcantly higher
than in controls. No SMR or RR was presented, but presumably if one had been presented, it would be greater than 100 if expressed
on a scale comparable with the others shown in the table. *p < 0.05.Environmental contamination and diabetes
data from case–control studies done in areas
where exposure to nitrates in water is unusually
high would be particularly useful. 
The association between PCBs and type 1
diabetes was reported in only one small cross-
sectional study. The importance of this obser-
vation will be clearer if replicated by others,
especially using a prospective design. 
Data on health effects of arsenic were sug-
gestive of an association with type 2 diabetes.
Additional reports on diabetes in groups con-
suming water contaminated with arsenic,
where epidemiologic studies of other out-
comes have already been done (44–47), could
be useful. If an arsenic effect exists, however,
it is likely to affect few populations because
severe contamination is unusual.
TCDD appeared to be the only environ-
mental contaminant identiﬁed that could be
having widespread affects in the general popu-
lation. But data among populations with
background-level exposure came from just
two studies, each with limitations. Prospective
data on the relation between TCDD and type
2 diabetes are needed.
Although selected occupational exposures
may increase risk of type 2 diabetes, few spe-
cific agents were implicated in our review.
Additional data on diabetes among those with
exposure to N-nitroso compounds, arsenic,
TCDD, talc, and straight oil machining ﬂuids
would be of interest.
Environmental Contaminants and
Local Variation in Rates of Diabetes
The observation that prompted this review
was that hospitalization rates for diabetes var-
ied across the Areas of Concern (1). The great
majority of diabetes is type 2; therefore, the
variation in hospitalization rates is accounted
for by corresponding variation either in risk
factors for type 2 diabetes or in the medical
management of patients. Given that relative
body weight is such a strong risk factor for
type 2 diabetes, it is highest among the poten-
tial suspects accounting for geographic varia-
tion in rates of diabetes. Without the ability to
take this and other such accepted risk factors
for diabetes into account, it would be highly
speculative to assume a high rate of diabetes in
a given area was due to contamination. 
Nonetheless, areas with higher rates of
hospitalization could be those containing a
substantial portion of the population occupa-
tionally exposed to a diabetogenic agent.
Among the studies where an occupation was
associated with an increased rate of death
from diabetes, however, the rate was at most
doubled and was usually much lower. An
investigation of diabetes among workers
involved in engine manufacturing, as in the
Park and Mirer study (78), taking occupa-
tional physical activity into account, may be
worthwhile. (Windsor, Ontario, Canada, one
of the Areas of Concern, had an increase in
diabetes hospitalizations, is economically like
Detroit, and could have this industry there.)
Arsenic exposure from drinking water in the
Areas of Concern would seem an unlikely cul-
prit, but the possibility of occupational arsenic
exposure might be worth investigating.
Similarly, substantial variation in contamina-
tion of the food supply with TCDD seems
unlikely, but again, the possibility of occupa-
tional exposure may be worth considering.
β-Cell Toxins and Type 2 Diabetes 
Type 1 and type 2 diabetes have no estab-
lished risk factors in common (see above). In
searching for new risk factors, however, it
may be worthwhile to consider that there
could be overlap in the risk factors for these
two types of diabetes. Both type 1 and type 2
diabetes have β-cell insufﬁciency, to a greater
or lesser extent, as part of their pathogenesis.
The β-cell toxin streptozotocin, typically used
to induce type 1 diabetes in animals, under
certain conditions can cause type 2 diabetes
(90). Thus, for example, examining
nitrosamine intake as a risk factor for type 2
diabetes could be worthwhile.
Summary
With respect to variation in diabetes rates in
the Areas of Concern, our review points to no
obvious environmental contaminants that
might explain the variation in diabetes rates.
Several occupations and occupational expo-
sures were identiﬁed, however, that may have
contributed. In general terms regarding envi-
ronmental contaminants as etiologic agents
for diabetes, data on arsenic and TCDD were
suggestive but inconclusive with respect to
type 2 diabetes, and for type 1 diabetes data
on intake of nitrates, nitrites, and N-nitroso
compounds were less suggestive but not com-
pletely null. Apart from the exposures consid-
ered in this review, other environmental
contaminants could be related to risk of
diabetes; however, no specific clues were
uncovered in the epidemiologic literature.
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